Rapid response with ketamine on suicidal cognition in resistant depression

Indian Journal of Psychological Medicine

Volumn 34, Issue 2, 2012, Pages 170-175

  Bhattacharya, Amit ^a   Bisui, Bikash ^b   Das, Ranjan ^a   Saha, Debasish ^a   Sen, Sreyashi ^b   Thakurta, Rajarshi ^a   Singh, Om Prakash ^a  

^a BURDWAN MEDICAL COLLEGE AND HOSPITAL   (India)

^b IPGMER ^*  (India)

Author keywords

Glutamate; Ketamine; Suicidal cognition; Treatment resistant depression

Indexed keywords

EID: 84867364074     PISSN: 02537176     EISSN: 09751564     Source Type: Journal    
DOI: 10.4103/0253-7176.101793     Document Type: Article

References (28)

1. Claassen CA, Trivedi MH, Rush AJ, Husain MM, Zisook S, Young E, et al. Clinical differences among depressed patients with and without a history of suicide attempts: Findings from the STARD trial. J Affect Disord 2007;97:77-84
2. Deisenhammer EA, Ing CM, Strauss R, Kemmler G, Hinterhuber H, Weiss EM. The duration of the suicidal process: How much time is left for intervention between consideration and accomplishment of a suicide attempt? J Clin Psychiatry 2009;70:19-24
3. Hunt IM, Kapur N, Webb R, Robinson J, Burns J, Shaw J, et al. Suicide in recently discharged psychiatric patients: A case-control study. Psychol Med 2009;39:443-9
4. Janofsky JS. Reducing inpatient suicide risk: Using human factors analysis to improve observation practices. J Am Acad Psychiatry Law 2009;37:15-24
5. Mills PD, DeRosier JM, Ballot BA, Shepherd M, Bagian JP. Inpatient suicide and suicide attempts in Veterans Affairs hospitals. Jt Comm J Qual Patient Saf 2008;34:482-8
6. Y Yeager KR, Saveanu R, Robers AR, et al. Measured response to identified suicide risk and violence: what you need to know about psychiatric patient safety. Brief Treat Crisis Interven. 2005;5:121-141.(text book)
7. Jick H, Kaye JA, Jick SS. Antidepressants and the risk of suicidal behaviors. JAMA 2004;292:338-43
8. Kellner CH, Fink M, Knapp R, Petrides G, Husain M, Rummans T, et al. Relief of expressed suicidal intent by ECT: A consortium for research in ECT study. Am J Psychiatry 2005;162:977-82
9. Szanto K, Mulsant BH, Houck P, Dew MA, Reynolds CF 3rd. Occurrence and course of suicidality during short-term treatment of late-life depression. Arch Gen Psychiatry 2003;60:610-7
10. Baldessarini RJ, Tondo L, Davis P, Pompili M, Goodwin FK, Hennen J. Decreased risk of suicides and suicide attempts during long-term lithium treatment: A meta-analytic review. Bipolar Disord 2006;8:625-39
11. Guzzetta F, Tondo L, Centorrino F, Baldessarini RJ. Lithium treatment reduces suicide risk in recurrent major depressive disorder. J Clin Psychiatry 2007;68:380-3
12. Meltzer HY, Alphs L, Green AI, Altamura AC, Anand R, Bertoldi A, et al. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch Gen Psychiatry 2003;60:82-91
13. Mathew SJ, Murrough JW, Aan Het Rot M, Collins KA, Reich DL, Charney DS. Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: A pilot randomized, placebo-controlled continuation trial. Int J Neuropsychopharmacol 2010;13:71- 82
14. Ernst CL, Goldberg JF. Antisuicide properties of psychotropic drugs: A critical review. Harv Rev Psychiatry 2004;12:14-41
15. Sackeim HA. The definition and meaning of treatmentresistant depression. J Clin Psychiatry 2001;62 (Suppl 16):10- 7
16. First MB, Spitzer RL, Gibbon M, Williams AR. Structured clinical interview for DSM-IV TR Axis I disorders, research version, patient edition (SCID-I/P). New York: New York State Psychiatric Institute, Biometrics Research; 2001
17. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62
18. Beck AT, Kovacs M, Weissman A. Assessment of suicidal intention: The scale for suicide Ideation. J Consult Clin Psychol 1979;47:343-52
19. Holi MM, Pelkonen M, Karlsson L, Kiviruusu O, Ruuttu T, Heilä H, et al. Psychometric properties and clinical utility of the Scale for Suicidal Ideation (SSI) in adolescents. BMC Psychiatry 2005;5:8
20. Overall JE, Gorham DR. The brief psychiatric rating scale. Psychol Rep 1962;10:799-812
21. Reeves H, Batra S, May RS, Zhang R, Dahl DC, Li X. Efficacy of risperidone augmentation to antidepressants in the management of suicidality in major depressive disorder: A randomized, double-blind, placebo-controlled pilot study. J Clin Psychiatry 2008;69:1228-336
22. Patel M, Patel S, Hardy DW, Benzies BJ, Tare V. Should electroconvulsive therapy be an early consideration for suicidal patients? J ECT 2006;22:113-5
23. DiazGranados N, Ibrahim LA, Brutsche NE, Ameli R, Henter ID, Luckenbaugh DA, et al. Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder. J Clin Psychiatry 2010;71:1605- 11
24. Zarate CA Jr, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, et al. A randomized trial of an N-methyl- D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 2006;63:856-64
25. Moghaddam B, Adams B, Verma A, Daly D. Activation of glutamatergic neurotransmission by ketamine: A novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 1997;17:2921-7
26. Maeng S, Zarate CA Jr, Du J, Schloesser RJ, McCammon J, Chen G, et al. Cellular mechanisms underlying the antidepressant effects of ketamine: Role of alpha-amino-3- hydroxy-5-methylisoxazole-4-propionic acid receptors. Biol Psychiatry 2008;63:349-52
27. White PF, Schuttler J, Shafer A, Stanski DR, Horai Y, Trevor AJ. Comparative pharmacology of the ketamine isomers: Studies in volunteers. Br J Anaesth 1985;57:197- 203
28. Rao TS, Andrade C. Innovative approaches to treatmentrefractory depression: The ketamine story. Indian J Psychiatry 2010;52:97-9